跳至主要内容
临床试验/ChiCTR-IIC-16010249
ChiCTR-IIC-16010249尚未招募Unknown

高能量聚焦式超音波(HIFU)治療無排卵性不孕的卵巢多囊症婦女之劑量研究

未提供1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 1990年1月1日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
30
试验地点
1
主要终点
To prospectively evaluate the feasibility and efficacy of HIFU in inducing ovulation in PCOS women.

研究概览

简要总结

高能量聚焦式超音波(HIFU)治療無排卵性不孕的卵巢多囊症婦女之劑量

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 40(—)
性别
Female

入选标准

  • Premenopausal women aged 18 to 40 years diagnosed with PCOS with anovulatory infertility;
  • Ability to give informed consent;
  • Body mass index <30 kg/m2;
  • Not on hormonal therapy (GnRH or combined oral contraceptive pills - COC) at the time of HIFU treatment;
  • No previous history of laparoscopic ovarian drilling or ovarian surgery;
  • Women with patent bilateral tubes;
  • Failure to achieve ovulation or pregnancy with incremental doses of clomiphene citrate;
  • Ability to give communicate clearly with a nurse or physician during HIFU treatment;
  • Women willing and able to comply with study requirements.

排除标准

  • Pre-existing thyroid problem or hyperprolactinaemia which may cause anovulation;
  • Those with pre-existing compromised ovarian failure as evident by day 2 FSH >10IU/L or an AMH value of <0.75ng/ml before the treatment;
  • Pregnant or lactating;
  • Presence of active pelvic inflammatory disease, genital or extra-genital malignancy;
  • Extensive scarring along anterior lower abdominal wall (greater than 50% of area) or scar tissue or surgical clips in the direct path of the HIFU;
  • Unable to give consent or those who are unable for regular follow- ups after the study;
  • Those with an intrauterine device in situ;
  • Those with tattoos or metalic implants over their abdomen;
  • Male partner with moderate to severe male factor.

研究组 & 干预措施

Case series

All sonographically guided HIFU procedures will be performed with the same HIFU system (HIFU-2001; SJTU Suntec Industry, Shanghai, China)

结局指标

主要结局

To prospectively evaluate the feasibility and efficacy of HIFU in inducing ovulation in PCOS women.

次要结局

  • To determine the acute, medium-term and long-term endocrine changes after HIFU and compare the changes to those reported after LOD.(for follow-up daily for 5 days after the procedure, weekly for 6 weeks then at 6 months after HIFU)
  • To determine the lowest effective dose of ultrasound energy used during HIFU in the induction of ovulation in women with PCOS.(for follow-up daily for 5 days after the procedure, weekly for 6 weeks then at 6 months after HIFU)
  • To determine the safety of HIFU in the treatment of PCOS, including the possible risk of compromised ovarian function.(for follow-up daily for 5 days after the procedure, weekly for 6 weeks then at 6 months after HIFU)

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验